-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In accordance with the national top-level policy design, the medical insurance drug catalogs of all provinces must be cleaned up in an orderly manner: the drugs in the key monitoring catalogs are first removed from the medical insurance catalogs; in principle, the remaining local supplementary varieties will be cleared within three years, and the proportions of the three-year cleared varieties are 40%, 40%, and 40% respectively.
Recently, the Hebei Provincial Medical Insurance Bureau and the Department of Human Resources and Social Security jointly issued the "Notice on Adjusting the "Hebei Province Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2020 Edition)"
Many other provinces have similar regulations
The "transition period" generally refers to the time between the removal of the provincial catalog and the end of the reimbursement policy
The rationality and compliance of the "transition period"
The rationality and compliance of the "transition period"Nothing prohibits the law
After the "transition period", the sales situation of the removed varieties
After the "transition period", the sales situation of the removed varietiesThat is not in the medical insurance catalogue, and pharmaceutical companies have many situations to deal with: one is not to reduce prices, and try their best to maintain hospital-side sales and expand out-of-hospital sales; second, to actively reduce prices, try to maintain hospital-side sales and expand out-of-hospital sales; third, from the base Drug catalogs, Chinese medicine departments, over-the-counter drugs and other fields are looking for opportunities to increase volume
After the "transition period", how to seize the opportunity for the cleared varieties?
After the "transition period", how to seize the opportunity for the cleared varieties?The medical insurance benefit list will cover the scope of the medical insurance drug list, and all the ways to be included in the national medical insurance drug list have been made public
A side effect of the timetable for the removal of varieties from the provincial catalogue is that these varieties scattered in various provinces, some of the exclusive varieties are very weak, and may disappear